New York AG Interest In Off-Label Promotion Extends Beyond GSK, Forest
Executive Summary
The New York Attorney General's interest in potential off-label promotion cases goes beyond pediatric use of antidepressants, New York State Assistant Attorney General Rose Firestein told a Food & Drug Law Institute advertising and promotion conference Sept. 13 in Washington, D.C
You may also be interested in...
Texas Considering Suits To Compel Average Manufacturer Price Reporting
Drug manufacturers may face lawsuits for failing to provide average manufacturer price information to states that have requested it
Off-Label Use “Predictions” May Be Scrutinized, Prosecutor Sheehan Says
Companies may include predictions of off-label use in their business plans but should be careful not to cross the line into encouraging off-label promotion, Philadelphia Associate U.S. Attorney James Sheehan suggested at a Food and Drug Law Institute advertising conference in Washington, D.C
Texas Considering Suits To Compel Average Manufacturer Price Reporting
Drug manufacturers may face lawsuits for failing to provide average manufacturer price information to states that have requested it